Maximum quantity allowed is 999
请选择数量
CAS RN: 13292-46-1 | 产品编码: R0079
Rifampicin

技术规格
Appearance | Orange to Amber to Dark red powder to crystal |
Purity(HPLC) | min. 94.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
NMR | confirm to structure |
物性(参考值)
熔点 | 188 °C(dec.) |
溶解性(可溶于) | 二甲基甲酰胺 |
GHS
象形图 |
![]() |
信号词 | Warning |
危险性说明 | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相关法规
RTECS# | VJ7000000 |
运输信息
HS编码* | 2941.90-000 |
应用
Rifampicin: A Rifamycin Antibiotic with Activity against a Wide Variety of Organisms including Tuberculosis Germs
Rifampicin (other name: rifampin) is a semisynthetic rifamycin antibiotic, which is chemically synthesized from rifamycin, which is isolated from a strain of the actinomycete Amycolatopsis mediterranei. Rifampicin has activity against a wide variety of organisms, including tuberculosis germs and Staphylococcus aureus, as well as in vitro activity against penicillin-resistant Streptococcus pneumoniae, and many Gram-negative bacteria. Rifampicin inhibits bacterial DNA-dependent RNA synthesis by inhibiting bacterial DNA-dependent RNA polymerase, which is responsible for DNA transcription. In contrast, the corresponding mammalian enzymes are not affected by rifampicin. Bacterial resistance to rifampicin is caused by mutations leading to a change in the structure of the β subunit of RNA polymerase. Rifampicin acts as a cytochrome P450 3A4 (CYP3A4) inducer, which increase the activity of CYP3A4. Thus, rifampicin can cause drug interaction with other medications.
References
- Rifampin: A Semisynthetic derivative of rifamycin. Prototype for the future (a review)
- Rifampin, a useful drug for nonmycobacterial infections (a review)
- Rifampin: mechanisms of action and resistance
- Pharmacokinetic interactions with rifampicin: Clinical relevance
- Rifampin and rifabutin drug interactions. An update
参考文献
文档
技术文章
产品文档 (部分产品的分析图谱无法提供,敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注:该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉,您搜索的分析图谱无法提供。